Literature DB >> 28601064

Types of Immune-Inflammatory Responses as a Reflection of Cell-Cell Interactions under Conditions of Tissue Regeneration and Tumor Growth.

L A Tashireva1, V M Perelmuter, V N Manskikh, E V Denisov, O E Savelieva, E V Kaygorodova, M V Zavyalova.   

Abstract

Inflammatory infiltration of tumor stroma is an integral reflection of reactions that develop in response to any damage to tumor cells including immune responses to antigens or necrosis caused by vascular disorders. In this review, we use the term "immune-inflammatory response" (IIR) that allows us to give an integral assessment of the cellular composition of the tumor microenvironment. Two main types of IIRs are discussed: type 1 and 2 T-helper reactions (Th1 and Th2), as well as their inducers: immunosuppressive responses and reactions mediated by Th22 and Th17 lymphocytes and capable of modifying the main types of IIRs. Cellular and molecular manifestations of each IIR type are analyzed and their general characteristics and roles in tissue regeneration and tumor growth are presented. Since inflammatory responses in a tumor can also be initiated by innate immunity mechanisms, special attention is given to inflammation based on them. We emphasize that processes accompanying tissue regeneration are prototypes of processes underlying cancer progression, and these processes have the same cellular and molecular substrates. We focus on evidence that tumor progression is mainly contributed by processes specific for the second phase of "wound healing" that are based on the Th2-type IIR. We emphasize that the effect of various types of immune and stroma cells on tumor progression is determined by the ability of the cells and their cytokines to promote or prevent the development of Th1- or Th2-type of IIR. Finally, we supposed that the nonspecific influence on the tumor caused by the cytokine context of the Th1- or Th2-type microenvironment should play a decisive role for suppression or stimulation of tumor growth and metastasis.

Entities:  

Mesh:

Year:  2017        PMID: 28601064     DOI: 10.1134/S0006297917050029

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  5 in total

Review 1.  The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.

Authors:  Yongjiang Li; Ciceron Ayala-Orozco; Pradipta Ranjan Rauta; Sunil Krishnan
Journal:  Nanoscale       Date:  2019-09-18       Impact factor: 7.790

2.  Peripheral Blood Inflammatory Markers Can Predict Benign and Malignant Thyroid Nodules.

Authors:  Yuanyuan Deng; Jie Zhang; Guilin Zou; Shanshan Li; Zhaoxia Gong; Guanru Yue; Ping Fan; Jixiong Xu
Journal:  Int J Endocrinol       Date:  2022-06-26       Impact factor: 2.803

3.  Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes.

Authors:  Dmitry Aleksandrovich Zinovkin; Md Zahidul Islam Pranjol; Il'ya Andreevich Bilsky; Valeriya Alexandrovna Zmushko
Journal:  Cancer Microenviron       Date:  2018-07-14

4.  Karanahan: A Potential New Treatment Option for Human Breast Cancer and Its Validation in a Clinical Setting.

Authors:  Anastasia S Proskurina; Victoria V Kupina; Yaroslav R Efremov; Evgenia V Dolgova; Vera S Ruzanova; Genrikh S Ritter; Ekaterina A Potter; Svetlana S Kirikovich; Evgeniy V Levites; Alexandr A Ostanin; Elena R Chernykh; Oksana G Babaeva; Sergey V Sidorov; Sergey S Bogachev
Journal:  Breast Cancer (Auckl)       Date:  2022-02-14

5.  Effects of Helicobacter pylori on the expression levels of GATA-3 and connexin 32 and the GJIC function in gastric epithelial cells and their association by promoter analysis.

Authors:  Lihua Huang; Yinjie Guo; Dan Cao; Xiaoming Liu; Linfang Zhang; Ke Cao; Tingzi Hu; Yong Qi; Canxia Xu
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.